Fundraise
capAI announced a conditional £280,000 gross fundraise at 0.45p a share, with admission expected around 10 August 2026, to fund platform development and working capital.
Licence and Option Agreement for Ageotype
Capai PLC has been granted an exclusive worldwide licence to develop and commercialise Ageotype for 12 months from the LOA, with the licence expected to expire on 22 July 2027. The agreement also gives capAI a discretionary option to acquire the associated IP for £2,000,000.
Extension of Licence and Option Agreements
capAI PLC has extended the licence periods for Author42 and Movie42 to 11.59 p.m. on 7 July 2027. The Gamers42 longstop date has also moved to 7 July 2027, with the non-binding MVP target date revised to 31 March 2027.